Why the study?
The role of PCI in stable coronary disease has been reappraised following evidence that optimal medical therapy may provide similar cardiovascular outcomes without incremental benefits from PCI.
Does percutaneous coronary intervention improve cardiovascular outcomes compared to optimal medical therapy in patients with stable coronary disease?
Does percutaneous coronary intervention improve cardiovascular outcomes compared to optimal medical therapy in patients with stable coronary disease?
Answers are grounded in this paper and cite their sources.
In stable coronary disease, PCI does not improve hard cardiovascular outcomes compared to optimal medical therapy, reinforcing contemporary guideline advice.
P ercutaneous coronary intervention (PCI) has guide line recommendations for treatment of ST elevation and non-ST elevation myocardial infarction (MI).1 However, its role in stable coronary disease has been the subject of reappraisal following publication of the COURAGE trial, which showed that, in patients receiving optimal medical therapy, PCI does not improve cardiovascular outcomes, while incremental benefits for quality of life disappear by 36 months.2 3 A more recent meta-analysis of eight trials of optimal medical therapy versus PCI involving 7229 patients bears out the COURAGE conclusions by showing no significant differences between the groups with regard to death (9.1% vs 8.9%), non-fatal MI (8.1% vs 8.9%), unplanned revascularisation (30.7% vs 21.4%) and persistent angina (33% vs 29%).4 Drug-eluting stents (DESs) were used in only a minority of these patients and may have reduced the need for further revascularisation while improving symptomatic responses. Nevertheless, the meta-analysis reinforces contemporary guideline advice for optimal medical treatment as the initial treatment for stable angina.5 Whether this will change current practice remains to be seen, but early signs are not encouraging. Thus a US registry analysis of patients undergoing PCI before (n=173416) and after (n=293 795) the COURAGE report showed no change in the proportions receiving optimal medical treatment (43.5% vs 44.7%).6
No takes yet. Share an insight, caveat, or question.
Meier et al. (2013) conducted a review in Cardiovascular disease. Cardiovascular interventions and therapies was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: